Carbamazepine
Trovati 6 articoli
- Antiepileptics linked to risk of suicidal thoughts and behavior
- The FDA ( Food and Drug Administration ) issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions. ... (Leggi Articolo)
- Stevens-Johnson syndrome linked to Ibuprofen
- Stevens-Johnson syndrome ( SJS ) is a severe blistering rash affecting both skin and mucous membranes. The majority of cases have been attributed to drug exposures. The reaction begins with burning and painful lesions on the face and upper torso and extends to the rest of the body. Blistering an... (Leggi Articolo)
- Aripiprazole for maintaining efficacy in bipolar I disorder
- The U.S. FDA ( Food and Drug Administration ) approved Aripiprazole ( Abilify ) for maintaining efficacy in patients with bipolar I disorder with a recent manic or mixed episode who had been stabilized and then maintained for at least six weeks. This new, expanded, indication is based on the ... (Leggi Articolo)
- Aripiprazole IM in patients with acute bipolar mania and schizophrenia
- In two double-blind, randomized, multicenter studies evaluated the investigational use of intramuscular ( IM ) Aripiprazole ( Abilify ) in patients with either acute bipolar mania or schizophrenia. The primary efficacy measure for both studies was mean change from baseline to two hours post-i... (Leggi Articolo)
- Vfend may be better than Fungizone for invasive aspergillosis survival
- The retrospective analysis, published in the Clinical Infectious Diseases, showed that patients who initially received antifungal agent Vfend ( Voriconazole ) were more likely to survive than patients who initially received Amphotericin B deoxycholate ( Fungizone ). The analysis also showed that ... (Leggi Articolo)
- Delayed therapy is the best option for single or infrequent seizures
- A randomised trial found that giving individuals with single or infrequent seizures immediate treatment does not reduce their risk of seizure recurrence in the long-term. The authors also saw that delaying medication did not increase the risk of chronic epilepsy in this group of people. The r... (Leggi Articolo)
